Ocugen Inc. buy BiotechBee
Start price
26.05.24
/
50%
€1.63
Target price
28.02.26
€3.50
Performance (%)
-49.35%
End price
14.12.24
€0.82
Summary
This prediction ended on 14.12.24 with a price of €0.82. The BUY prediction by BiotechBee for Ocugen Inc. performed very badly with a performance of -49.35%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ocugen Inc. | 12.739% | 12.739% | 161.362% |
| iShares Core DAX® | -0,38 % | 1,09 % | 11,64 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % | 7,27 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % | 31,38 % |
| iShares S&P 500 | -0,71 % | 0,44 % | 4,30 % |
According to BiotechBee what are the pros and cons of Ocugen Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year